News & Events about Optimizerx Corporation.
B. Riley restated their buy rating on shares of OptimizeRx (NASDAQ:OPRX Get Rating) in a research report report published on Thursday, The Fly reports. They currently have a $30.00 target price on the stock. A number of other equities analysts have also recently weighed in on the company. Stifel ...
OPRX CEO Will Febbo provides business update and key industry trendsOPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich., Jan. 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company)(Nasdaq: OPRX),a leading provider of point-of-care technology solutions ...
Globe Newswire
2 months ago
ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company) (Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following upcoming investor conferences: ...
Globe Newswire
3 months ago
Virtual event takes place December 1, 2022ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp(the Company) (Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the third annual Innovate4Outcomes event co-...
Globe Newswire
5 months ago
Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for doctors and patients navigating Medicare coverage gaps ROCHESTER, Mich., Aug. 23, 2022 (GLOBE NEWSWIRE...